Tajinder S. Vohra - 21 Dec 2022 Form 4 Insider Report for PERKINELMER INC (RVTY)

Signature
/s/ John L. Healy (POA on file) for Tajinder S. Vohra
Issuer symbol
RVTY
Transactions as of
21 Dec 2022
Net transactions value
-$306,932
Form type
4
Filing time
23 Dec 2022, 15:05:15 UTC
Previous filing
21 Dec 2022
Next filing
01 Feb 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVTY Common Stock Options Exercise $81,396 +1,662 +9.7% $48.98 18,867 21 Dec 2022 Direct
transaction RVTY Common Stock Sale $50,885 -362 -1.9% $140.57 18,505 21 Dec 2022 Direct F1, F2
transaction RVTY Common Stock Sale $101,460 -712 -3.8% $142.50 17,793 21 Dec 2022 Direct F1, F3
transaction RVTY Common Stock Sale $84,358 -588 -3.3% $143.47 17,205 21 Dec 2022 Direct F1, F4
transaction RVTY Common Stock Options Exercise $81,445 +1,663 +9.7% $48.98 18,868 22 Dec 2022 Direct
transaction RVTY Common Stock Sale $80,739 -580 -3.1% $139.21 18,288 22 Dec 2022 Direct F1, F5
transaction RVTY Common Stock Sale $94,470 -673 -3.7% $140.37 17,615 22 Dec 2022 Direct F1, F6
transaction RVTY Common Stock Sale $57,861 -410 -2.3% $141.12 17,205 22 Dec 2022 Direct F1, F7

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RVTY NQ Stock Option (right to buy) Options Exercise $0 -1,662 -50% $0.000000 1,663 21 Dec 2022 Common Stock 1,662 $48.98 Direct F8
transaction RVTY NQ Stock Option (right to buy) Options Exercise $0 -1,663 -100% $0.000000* 0 22 Dec 2022 Common Stock 1,663 $48.98 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by Mr. Vohra on November 16, 2022.
F2 The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $140.25 to $140.74. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
F3 The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $142.13 to $143.09. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
F4 The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $143.25 to $143.66. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
F5 The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $138.85 to $139.72. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
F6 The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $139.95 to $140.75. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
F7 The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $140.95 to $141.36. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
F8 This option became exercisable in three equal annual installments beginning on March 4, 2017, which was the first anniversary of the date on which the option was granted.

Remarks:

Senior Vice President, Global Operations